SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7.00 |
Enterprise Value ($M) | 5.40 |
Book Value ($M) | 1.62 |
Book Value / Share | 0.07 |
Price / Book | 4.32 |
NCAV ($M) | -0.43 |
NCAV / Share | -0.02 |
Price / NCAV | -16.41 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -13.20 |
Return on Assets (ROA) | -1.70 |
Return on Equity (ROE) | -2.44 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.83 |
Current Ratio | 0.83 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.08 |
Assets | 4.12 |
Liabilities | 2.50 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -21.17 |
Net Income | -21.39 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -17.15 |
Cash from Investing | 0.00 |
Cash from Financing | 12.01 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Forsakringsaktiebolaget Avanza Pension | 0.02 | -95.43 | |
13G/A | Otsuka Masaya | 0.00 | -100.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
805,540 | 2,165,498 | 37.20 | |
276,615 | 1,128,161 | 24.52 | |
593,711 | 1,904,365 | 31.18 | |
1,785,343 | 5,377,143 | 33.20 | |
(click for more detail) |
Similar Companies | |
---|---|
GLTO – Galecto, Inc. | GLYC – GlycoMimetics, Inc. |
GNLX – Genelux Corporation | GOVX – GeoVax Labs, Inc. |
GRCE – Grace Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io